3 Millionaire-Maker Quantum Computing Stocks Wall Street Isn't Talking About

IonQ raised its 2026 revenue guidance to $450 million-$460 million following its SkyWater Technology acquisition, which adds in-house semiconductor manufacturing capabilities, and plans to deploy its Superion 256 system at Nvidia's Accelerated Quantum Research Center. D-Wave and Rigetti each secured agreements for up to $100 million in U.S. CHIPS and Science Act funding to advance quantum R&D, while D-Wave has commercial deployments with AT&T, Nasdaq Verafin, and NTT DOCOMO. The developments reinforce growing commercial and government support for quantum computing, although the investment case remains speculative given the technology's early stage.

Analysis

The investable distinction is increasingly not qubit count but funding runway and route to paid workloads. IONQ’s expanded revenue base should reduce its apparent pure-play quantum exposure, but it also introduces foundry cyclicality, integration execution, and lower-margin manufacturing revenue; the key question for the next 1-3 quarters is whether incremental revenue converts to gross profit and backlog rather than merely enlarging the top-line denominator. SKYT customers could benefit from greater capital access, while competing domestic specialty foundries face a more credible, vertically integrated bidder for government-supported programs.

QBTS has the clearest near-term commercialization narrative, but enterprise pilots rarely become material recurring revenue on the timetable implied by retail-style quantum valuations. Its strategic move into gate-model hardware creates optionality but also risks diluting the differentiated annealing proposition and increasing cash burn against much better-capitalized superconducting competitors including IBM, GOOG and RGTI. The relevant catalyst is disclosed contract value, production renewals, and gross-margin trajectory over the next 6-12 months—not customer logos.

Government awards lower financing risk but should not be capitalized as operating revenue: milestone timing, cost-share requirements, and restrictions on use of proceeds can leave cash needs largely intact. The contrarian view is that hyperscalers and NVDA may capture more near-term economic value through hybrid orchestration, error-correction software, and accelerated simulation than public quantum pure plays capture in hardware. Quantum equities remain highly duration-sensitive; a rise in real yields, a secondary offering, or delayed technical milestones can compress multiples sharply within days.

IONQ is comparatively better positioned for institutional ownership if it demonstrates a clean separation of quantum versus foundry economics. QBTS and RGTI are higher-beta event vehicles rather than fundamental compounders until bookings, cash burn, and technical performance independently validate the narratives. There is no compelling broad directional trade after promotional coverage alone; wait for earnings disclosures and financing terms.

Key Decisions for Investors

• Maintain a relative-value long IONQ / short equal-beta RGTI position over 3-6 months only if IONQ reports improving quantum bookings and no deterioration in pro forma gross margin; target 15-20% spread appreciation, stop at a 10% adverse spread move or a materially dilutive IONQ financing.
• Use QBTS only as a small, catalyst-driven long into verified enterprise conversion or backlog disclosure over the next 1-3 quarters; cap position size given binary technical and funding risk. Exit if quarterly cash burn accelerates without contracted revenue growth or if management shifts milestone timing.
• For lower-volatility exposure, favor NVDA or IBM over quantum pure plays for the 6-18 month hybrid-computing spend cycle; these companies can monetize tooling and services even if fault-tolerant quantum deployment slips. Reassess if quantum revenue becomes material enough to alter their segment guidance.
• Set alerts around secondary offerings, ATM activity, and award payment schedules for IONQ, QBTS, and RGTI. Any financing announced after a momentum-driven rally is a potential short-term short catalyst, particularly if cash runway remains below 24 months.
• Avoid treating the stated revenue outlook as organic quantum demand until management provides acquired-versus-organic revenue, backlog, gross-margin, and capex detail; absent that disclosure, do not underwrite a multiple expansion in IONQ.